×

Sleep Apnea Diagnostic And Therapeutic Devices

Research and Markets logo

Dublin, Oct. 24, 2013 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/qv93nb/sleep_apnea) has announced the addition of the "Sleep Apnea Diagnostic And Therapeutic Devices - Global Strategic Business Report" report to their offering.

This report analyzes the worldwide markets for Sleep Apnea Diagnostic and Therapeutic Devices in US$ Million by the following Product Segments: Diagnostic Devices (Fixed PSG, Ambulatory PSG, & Others (include Screening Devices)), and Therapeutic Devices (CPAP, Bi-Level PAP, Auto PAP, & Facial Interfaces (Masks and Humidifiers)). The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. A six-year historic analysis is also provided for these markets.

The report profiles 68 companies including many key and niche players such as:

  • Grass Technologies
  • Cadwell Laboratories Inc.
  • CareFusion Corporation
  • Compumedics Ltd.
  • DeVilbiss Healthcare
  • Global Medical Holdings LLC
  • Fisher & Paykel Healthcare Limited
  • GE Healthcare
  • Vital Signs Inc.
  • Itamar Medical Ltd.
  • Invacare Corporation
  • Natus Medical Inc.
  • Bio-Logic
  • Embla Systems Inc.
  • Stellate Systems Inc.
  • Philips Healthcare
  • ResMed Inc.
  • Teleflex Medical
  • Weinmann Geräte für Medizin GmbH+CCo. KG.


Key Topics Covered:

I. Introduction, Methodology & Product Definitions

  • Study Reliability and Reporting Limitations I-1
  • Disclaimers I-2
  • Data Interpretation & Reporting Level I-2
  • Quantitative Techniques & Analytics I-3
  • Product Definitions and Scope of Study I-3
  • Diagnostic Devices I-3
  • Fixed PSG I-3
  • Ambulatory PSG I-3
  • Others (include Screening Devices) I-3
  • Therapeutic Devices I-4
  • CPAP I-4
  • Bi-Level PAP I-4
  • Auto PAP I-4
  • Facial Interfaces (Masks and Humidifiers) I-4

II. Executive Summary

1. MARKET OVERVIEW II-1

  • Current & Future Analysis II-1
  • Prevalence Statistics II-1
  • The US is the Clear Market Leader, Developing Regions Promise
  • Growth II-2
  • Segmental Analysis II-2

2. MARKET DYNAMICS II-3

  • Impact of Economic Recession on the Medical Device Industry II-3
  • Emergence of Dental Sleep Medicine II-3
  • Sleep Apnea/Sleep Disorders in Children Responsible for Obesity II-3
  • Changing Demographics to Play a Major Role II-4
  • Increased Awareness of Comorbid Conditions Spurs Market Growth II-4
  • Demerits of Present Diagnostic Procedures II-4
  • Technology Advancements Improve Patient Compliance II-4
  • Automated CPAP II-5
  • Humidification II-5
  • Patient-Friendly Masks II-5
  • Educational Campaigns II-5
  • Under-Penetration in CPAP Therapy Promises Significant Growth Prospects II-5
  • OSA Industry Witnesses Consistent M&A Activity II-5

3. COMPETITION AND MARKET STRUCTURE II-7

  • Resmed and Respironics Dominate Competitive Landscape II-7

4. SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC DEVICES - A SYNOPSIS II-8

  • Significance of Sleep II-8
  • Stages of Sleep II-8
  • Sleep Disorders and Stages of Sleep II-8
  • Sleep Apnea- Introduction II-8
  • Forms of Apnea II-9
  • Central Sleep Apnea II-9
  • Physiological Effects of CSA II-9
  • Mixed Apnea II-9
  • Complex Sleep Apnea II-9
  • Obstructive Sleep Apnea - An Overview II-10
  • History II-10
  • Causes of OSA II-10
  • Symptoms of OSA II-11
  • Snoring and OSA II-11
  • Risks and Complications Associated with Untreated Disorder II-11
  • Risk Groups II-11
  • Co-Morbid Conditions II-12
  • Heart Failure II-12
  • Hypertension II-12
  • Diabetes II-12
  • Fatigue II-12
  • Complications Associated with Surgery and Medications II-12
  • Financial Implications of Untreated OSA II-13
  • Pediatric OSA II-13

5. SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC DEVICES II-14

  • OSA Diagnosis II-14
  • Interpreting AHI II-14
  • AHI of 5 to 15: Mild OSA II-14
  • AHI of 15 to 30: Moderate OSA II-14
  • AHI of more than 30: Severe OSA II-14
  • Sleep Apnea Diagnostic Devices II-14
  • Polysomnography (PSG), and Types of Polysomnographs II-14
  • Clinical/Fixed Polysomnographs II-15
  • Ambulatory Polysomnographs II-15
  • Other Sleep Apnea Diagnostic Devices II-16
  • Screening Devices II-16
  • Actigraphs II-16
  • Sleep Apnea Therapeutic Devices II-16
  • Positive Airway Pressure (PAP) Treatment II-16
  • PAP Devices II-16
  • Continuous Positive Airway Pressure (CPAP) Devices II-16
  • Optional Features Available for CPAP Devices II-17
  • Bilevel Positive Airway Pressure (BiPAP) Devices II-17
  • Auto-titrating Positive Airway Pressure (APAP) Devices II-18
  • Facial Interfaces (Masks and Humidifiers) II-18
  • Alternative Apnea Therapies II-18
  • Oral Appliances II-18
  • Surgical Procedures II-19
  • Tracheostomy II-19
  • Uvulo-palato-pharyngoplasty (UPPP) II-19
  • Mandibular Myotomy II-19
  • Laser Assisted Uvuloplasty (LAUP) II-19
  • Somnoplasty or Radio Frequency (RF) Procedure II-19
  • Pillar Palatal Implant System II-20
  • Other Surgical Therapies II-20
  • Over-the-Counter and Pharmacological Therapies II-20
  • Behavioral and Lifestyle Changes II-20

6. RESEARCH FINDINGS II-21

  • Research Finds Link Between Sleep Apnea and Heart Risks in Children II-21
  • Sleep Disorders Increase Risk for Stroke and Blood Pressure Patients II-21
  • Individuals with Sleep Apnea Face Greater Risk of Cardiac Stress During Air Travel II-21
  • Sleep Apnea Screening Reduces Risk of Post Operative Complications II-21

7. PRODUCT LAUNCHES/INTRODUCTIONS II-22

  • US Researchers Develop Novel Sleep Apnea Diagnostic Device Based on Ultrasonic Sensors II-22
  • NovaSom Introduces MediTrack® II-22
  • ResMed Launches S9 Series for Sleep Apnea Therapy II-22
  • GE Healthcare Launches MARS® Virtual Sleep Lab II-23
  • Remote Analysis Launches iPhone Sleep Diagnostic Application II-23
  • Circadiance Unveils New Zzzephyr Seal II-23
  • Philips Launches New Sleep Therapy System II-24
  • ImThera Medical Unveils aura6000TM Neurostimulation System II-24
  • Philips Unveils Respironics Products in India II-24
  • CardioNet Introduces SomNet Cardiac Indicator II-24
  • FDA Grants 510(K) Clearance to Dormio Tech II-24
  • Ambu Acquires Sleepmate Technologies II-25
  • CIRCADIANTM Enters into Partnership with Sleep PointeTM for
  • Providing OSA Detection and Cure II-25
  • Medtronic Acquires Restore Medical II-25
  • Blackstone to Take Over Apria Healthcare II-25
  • Nihon Kohden Acquires Neurotronics II-25
  • Medtronic Snaps Up Repose GAHM Product Line of InfluENT Medical II-26
  • GE Healthcare Acquires Vital Signs II-26
  • CleveMed Enters into Collaboration with BIDMC Professor II-26
  • Royal Philips Acquires Respironics II-26
  • Cardinal Health Signs Agreement with SleepNet II-27
  • Nihon Kohden Signs New Agreement with Premier II-27

8. RECENT INDUSTRY ACTIVITY II-28

  • Dehaier Obtains CE Certification for Sleep Diagnostic Devices and Air Compressors II-28
  • CareCentrix Takes Over Sleep Management Solutions II-28
  • Natus Snaps Up Embla Systems II-28
  • Graymark Acquires Majority Stake in Village Sleep Center II-29
  • Continucare Expands Operations through Acquisitions II-29
  • Healthcare of Today to Acquire IMA and SC X-Ray II-29
  • Cyberonics Invests in ImThera, Acquires Minority Interest II-30
  • Graymark Healthcare and North Oak Medical Park Form Partnership II-30
  • Graymark Healthcare Sells Nocturna East Sleep Centers II-31
  • Watermark Medical Collaborates with AASM for OSA Diagnostic- Care Study II-31
  • AZ-TMJ Sets Up Sleep Apnea Treatment Unit II-31
  • Phyhealth Launches Subsidiary Phyhealth Sleep Care Centre II-31
  • WideMed Receives CE Certification for Mobile Sleep Apnea System II-32
  • WideMed Receives Order from GE Healthcare for Morpheus Hx Devices II-32
  • SleepQuest Buys Extra WatchPAT Devices from Itamar-Medical II-32
  • Coliseum Northside Hospital Opens Sleep Disorder Center II-32
  • Naturs Design Signs Partnership with Intus Healthcare II-33
  • Graymark Healthcare and Coryell Memorial Healthcare Ink Agreement II-33
  • Compumedics Obtains FDA Approval for GRAEL™ HD-PSG Sllep System II-33
  • Covidien Sells Sleep Therapy and Bi-level Products to PH Invest II-33
  • Embla Snaps Up Covidiens Sleep Diagnostic Business II-33
  • Graymark Healthcare Signs Joint Venture Agreement with Oklahoma Heart Hospital II-34
  • Ethicon Takes Over Acclarent II-34
  • Siix to Develop Sleep Disorders Tracking Device II-34
  • Blue Shield and Apria Healthcare Ink Agreement Group II-34
  • Peak Surgical Inks Distribution Agreement with Medtronic II-34
  • REM Medical, U.S. Health Works Enter into Partnership II-35
  • Graymark Healthcare Takes Over somniTech and somniCare II-35
  • ResMed Takes Over Laboratoires Narval II-35
  • Curative Medical Snaps Up BEVT II-35
  • Roadside Medical Clinic + Lab Enters into Joint Venture with Sleep Pointe II-35
  • Air Liquide Takes Over Comcare Medical II-36
  • REM Medical Takes Over Tucson Site of PsyPharma Global II-36
  • Formation of CareFusion II-36

9. FOCUS ON SELECT PLAYERS II-37

  • Grass Technologies (US) II-37
  • Cadwell Laboratories, Inc. (US) II-37
  • CareFusion Corporation (USA) II-37
  • Compumedics Ltd (Australia) II-38
  • DeVilbiss Healthcare (US) II-38
  • Global Medical Holdings LLC (US) II-39
  • Fisher & Paykel Healthcare Limited (New Zealand) II-39
  • GE Healthcare (US) II-39
  • Vital Signs Inc. (US) II-39
  • Itamar Medical Ltd. (Israel) II-40
  • Invacare Corporation (US) II-40
  • Natus Medical Inc. (US) II-40
  • Bio-Logic (US) II-40
  • Embla Systems, Inc. (US) II-41
  • Stellate Systems, Inc. (Canada) II-41
  • Philips Healthcare (USA) II-41
  • ResMed Inc. (US) II-42
  • Teleflex Medical (US) II-42
  • Weinmann Geräte für Medizin GmbH+CCo. KG (Germany) II-42

10. GLOBAL MARKET PERSPECTIVE II-43




III. Market

1. THE UNITED STATES

2. JAPAN

3. EUROPE

4. REST OF WORLD

IV. Competitive Landscape

Total Companies Profiled: 68 (including Divisions/Subsidiaries - 106)

  • The United States (51)
  • Canada (4)
  • Japan (2)
  • Europe (31)
  • - France (4)
  • - Germany (8)
  • - The United Kingdom (5)
  • - Italy (2)
  • - Spain (3)
  • - Rest of Europe (9)
  • Asia-Pacific (Excluding Japan) (13)
  • Latin America (2)
  • Middle East (3)

For more information visit http://www.researchandmarkets.com/research/qv93nb/sleep_apnea

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Diagnostics

Source:Research and Markets